News
AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE
AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.
News & Events
Keep up to date on AgNovos events and related news
Featured posts
All Articles
AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE
AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.
Corporate Rebranding Announcement
AgNovos Healthcare Announces Corporate Renaming as AgNovos Bioscience
AgNovos Healthcare to participate in 2022 British Orthopaedic Association Congress
AgNovos Healthcare is pleased to participate in this year’s British Orthopaedic Association Congress (BOA) from September 20-23 in Birmingham, England.
AgNovos Healthcare to Participate in German Osteology Congress (DVO)
o AgNovos Healthcare is pleased to participate in this year’s German Osteology Congress (DVO) from September 18-20 in Baden, Germany.
AgNovos Healthcare to Participate in ASBMR Conference
AgNovos Healthcare is attending this year's ASBMR conference highlighting important research on critical topics such as the drivers and dynamics of secondary fracture risk.
AgNovos Healthcare to Participate in Swiss Orthopaedics Congress
AgNovos is pleased to participate in this year’s Swiss Orthopaedics congress (SGO) from June 22-24 in Basel, Switzerland.